Detailed information for compound 1255224

Basic information

Technical information
  • TDR Targets ID: 1255224
  • Name: 3-(4-ethoxyphenyl)-6,6-di(phenyl)-3-azabicycl o[3.1.0]hexane-2,4-dione
  • MW: 383.439 | Formula: C25H21NO3
  • H donors: 0 H acceptors: 2 LogP: 4.3 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOc1ccc(cc1)N1C(=O)C2C(C1=O)C2(c1ccccc1)c1ccccc1
  • InChi: 1S/C25H21NO3/c1-2-29-20-15-13-19(14-16-20)26-23(27)21-22(24(26)28)25(21,17-9-5-3-6-10-17)18-11-7-4-8-12-18/h3-16,21-22H,2H2,1H3
  • InChiKey: HSWXAFPTYOSFRH-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 3-(4-ethoxyphenyl)-6,6-di(phenyl)-3-azabicyclo[3.1.0]hexane-2,4-quinone
  • 3-(4-ethoxyphenyl)-6,6-diphenyl-3-azabicyclo[3.1.0]hexane-2,4-dione
  • AO-081/14338047
  • MLS000702472
  • SMR000229395

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens ataxin 2 Starlite/ChEMBL No references
Homo sapiens SMAD family member 2 Starlite/ChEMBL No references
Homo sapiens glucagon-like peptide 1 receptor Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) transcription factor SMAD2 Get druggable targets OG5_131716 All targets in OG5_131716
Loa Loa (eye worm) MH2 domain-containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Brugia malayi MH2 domain containing protein Get druggable targets OG5_131716 All targets in OG5_131716

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi MH2 domain containing protein SMAD family member 2 467 aa 405 aa 31.6 %
Loa Loa (eye worm) pigment dispersing factor receptor c glucagon-like peptide 1 receptor 463 aa 388 aa 25.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis esterase, putative 0.0035 0.0164 0.5
Entamoeba histolytica protein kinase, putative 0.093 0.6486 1
Loa Loa (eye worm) pigment dispersing factor receptor c 0.006 0.0342 0.0292
Brugia malayi Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative 0.0035 0.0164 0.0113
Brugia malayi beta-lactamase family protein 0.0035 0.0164 0.0113
Mycobacterium ulcerans hypothetical protein 0.0035 0.0164 0.5
Echinococcus multilocularis GPCR, family 2 0.0019 0.0051 0.0059
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.0035 0.0164 0.0151
Mycobacterium leprae Probable lipase LipE 0.0035 0.0164 0.5
Loa Loa (eye worm) hypothetical protein 0.0035 0.0164 0.0113
Echinococcus multilocularis cadherin EGF LAG seven pass G type receptor 0.0019 0.0051 0.0059
Schistosoma mansoni hypothetical protein 0.0041 0.0208 0.0195
Mycobacterium leprae conserved hypothetical protein 0.0035 0.0164 0.5
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0223 0.1494 1
Loa Loa (eye worm) hypothetical protein 0.0035 0.0164 0.0113
Brugia malayi latrophilin 2 splice variant baaae 0.0041 0.0208 0.0157
Mycobacterium ulcerans lipase LipD 0.0035 0.0164 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0035 0.0164 1
Schistosoma mansoni serine/threonine protein kinase 0.093 0.6486 0.6481
Mycobacterium ulcerans esterase/lipase LipP 0.0035 0.0164 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.0132 0.8063
Echinococcus multilocularis beta LACTamase domain containing family member 0.0035 0.0164 0.0232
Schistosoma mansoni hypothetical protein 0.0019 0.0051 0.0038
Brugia malayi hypothetical protein 0.003 0.0132 0.0081
Schistosoma mansoni hypothetical protein 0.0019 0.0051 0.0038
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.0035 0.0164 0.0151
Echinococcus multilocularis serine:threonine protein kinase Chk2 0.093 0.6486 1
Trichomonas vaginalis D-aminoacylase, putative 0.0035 0.0164 0.5
Mycobacterium ulcerans fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE 0.0035 0.0164 0.5
Leishmania major hypothetical protein, conserved 0.003 0.0132 0.8063
Entamoeba histolytica protein kinase, putative 0.093 0.6486 1
Echinococcus multilocularis calcium:calmodulin dependent protein kinase I 0.0929 0.6483 0.9996
Echinococcus granulosus beta LACTamase domain containing family member 0.0035 0.0164 0.0232
Schistosoma mansoni serine/threonine protein kinase 0.1427 1 1
Echinococcus granulosus cadherin EGF LAG seven pass G type receptor 0.0019 0.0051 0.0059
Brugia malayi beta-lactamase 0.0035 0.0164 0.0113
Echinococcus granulosus calcium:calmodulin dependent protein kinase I 0.0929 0.6483 0.9996
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.006 0.0342 0.0292
Loa Loa (eye worm) hypothetical protein 0.0035 0.0164 0.0113
Loa Loa (eye worm) hypothetical protein 0.006 0.0342 0.0292
Echinococcus multilocularis diuretic hormone 44 receptor GPRdih2 0.0019 0.0051 0.0059
Onchocerca volvulus 0.0035 0.0164 0.5
Echinococcus granulosus diuretic hormone 44 receptor GPRdih2 0.0019 0.0051 0.0059
Brugia malayi Calcitonin receptor-like protein seb-1 0.006 0.0342 0.0292
Loa Loa (eye worm) beta-lactamase 0.0035 0.0164 0.0113
Loa Loa (eye worm) transcription factor SMAD2 0.0144 0.0936 0.0889
Mycobacterium ulcerans beta-lactamase 0.0035 0.0164 0.5
Trypanosoma brucei PAB1-binding protein , putative 0.003 0.0132 0.8063
Onchocerca volvulus 0.0035 0.0164 0.5
Trichomonas vaginalis penicillin-binding protein, putative 0.0035 0.0164 0.5
Schistosoma mansoni hypothetical protein 0.0019 0.0051 0.0038
Trypanosoma cruzi hypothetical protein, conserved 0.0035 0.0164 1
Schistosoma mansoni hypothetical protein 0.0019 0.0051 0.0038
Loa Loa (eye worm) hypothetical protein 0.003 0.0132 0.0081
Plasmodium vivax hypothetical protein, conserved 0.0035 0.0164 1
Loa Loa (eye worm) hypothetical protein 0.0041 0.0208 0.0157
Loa Loa (eye worm) MH2 domain-containing protein 0.0144 0.0936 0.0889
Toxoplasma gondii ABC1 family protein 0.0035 0.0164 1
Trichomonas vaginalis penicillin-binding protein, putative 0.0035 0.0164 0.5
Echinococcus granulosus GPCR family 2 0.0019 0.0051 0.0059
Loa Loa (eye worm) CAMK/CAMKL/CHK1 protein kinase 0.1427 1 1
Loa Loa (eye worm) beta-LACTamase domain containing family member 0.0035 0.0164 0.0113
Brugia malayi beta-lactamase family protein 0.0035 0.0164 0.0113
Trichomonas vaginalis D-aminoacylase, putative 0.0035 0.0164 0.5
Loa Loa (eye worm) hypothetical protein 0.0035 0.0164 0.0113
Trichomonas vaginalis D-aminoacylase, putative 0.0035 0.0164 0.5
Onchocerca volvulus 0.0035 0.0164 0.5
Loa Loa (eye worm) hypothetical protein 0.0035 0.0164 0.0113
Brugia malayi hypothetical protein 0.002 0.0056 0.0004
Leishmania major hypothetical protein, conserved 0.0035 0.0164 1
Echinococcus granulosus serine:threonine protein kinase Chk2 0.093 0.6486 1
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.0132 0.5
Brugia malayi MH2 domain containing protein 0.0144 0.0936 0.0889
Trypanosoma brucei hypothetical protein, conserved 0.0035 0.0164 1
Loa Loa (eye worm) hypothetical protein 0.0035 0.0164 0.0113
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.0132 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.0132 0.8063

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 5.0119 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 5.8584 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 7.0795 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 9.285 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 15.8489 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) = 22.3872 um PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 25.929 uM PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] ChEMBL. No reference
Potency (functional) 29.0929 uM PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] ChEMBL. No reference
Potency (functional) 44.6684 uM PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) ChEMBL. No reference
Potency (binding) = 50.1187 um PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] ChEMBL. No reference
Potency (functional) 50.1187 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 75.6863 uM PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.